This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) slumped 0.35% to $2.85 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.09% to 32,832.54 and the S&P 500 Index falling 0.12% to 4,140.06. The stock's fall snapped a four-day winning streak. Ocugen Inc. closed $14.80 short of its 52-week high ($17.65), which the company achieved on November 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Adverum Biotechnologies Inc. (ADVM) fell 5.59% to $1.52, Ocular Therapeutix Inc. (OCUL) rose 2.02% to $5.06, and Kodiak Sciences Inc. (KOD) rose 14.07% to $11.11. Trading volume (4.5 M) remained 1.6 million below its 50-day average volume of 6.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 8, 2022.
(END) Dow Jones Newswires
August 08, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.